Journal article
Mapping ErbB receptors on breast cancer cell membranes during signal transduction
Journal of cell science, Vol.120(Pt 16), pp.2763-2773
08/15/2007
DOI: 10.1242/jcs.007658
PMID: 17652160
Abstract
Distributions of ErbB receptors on membranes of SKBR3 breast cancer cells were mapped by immunoelectron microscopy. The most abundant receptor, ErbB2, is phosphorylated, clustered and active. Kinase inhibitors ablate ErbB2 phosphorylation without dispersing clusters. Modest co-clustering of ErbB2 and EGFR, even after EGF treatment, suggests that both are predominantly involved in homointeractions. Heregulin leads to dramatic clusters of ErbB3 that contain some ErbB2 and EGFR and abundant PI 3-kinase. Other docking proteins, such as Shc and STAT5, respond differently to receptor activation. Levels of Shc at the membrane increase two- to five-fold with EGF, whereas pre-associated STAT5 becomes strongly phosphorylated. These data suggest that the distinct topography of receptors and their docking partners modulates signaling activities.
Details
- Title: Subtitle
- Mapping ErbB receptors on breast cancer cell membranes during signal transduction
- Creators
- Shujie Yang - Department of Pathology and Cancer Research and Treatment Center, University of New Mexico, Albuquerque, NM 87131, USAMary Ann Raymond-StintzWenxia YingJun ZhangDiane S LidkeStanly L SteinbergLance WilliamsJanet M OliverBridget S Wilson
- Resource Type
- Journal article
- Publication Details
- Journal of cell science, Vol.120(Pt 16), pp.2763-2773
- DOI
- 10.1242/jcs.007658
- PMID
- 17652160
- NLM abbreviation
- J Cell Sci
- ISSN
- 0021-9533
- eISSN
- 1477-9137
- Publisher
- England
- Grant note
- P20 GM067594 / NIGMS NIH HHS R01 CA119232 / NCI NIH HHS
- Language
- English
- Date published
- 08/15/2007
- Academic Unit
- Pathology; Internal Medicine
- Record Identifier
- 9984046829902771
Metrics
20 Record Views